China NMPA Drug Inspection - Inner Mongolia Tengyitang Pharmaceutical Co., Ltd. - Liquidambar resin

The Inner Mongolia Autonomous Region Food and Drug Administration (IMAFDA) announced on December 29, 2017, the results of drug quality sampling inspections. These inspections, conducted by various regional drug inspection institutes, identified that seven batches of Chinese medicinal materials and processed Chinese medicinal herbs from several manufacturers failed to meet established quality standards.